Louis Lantier

4PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 16, 2023
Nasal administration of recombinant Neospora caninum secreting IL-15/IL-15Rα inhibits metastatic melanoma development in lung.

Arthur Battistoni, Louis Lantier, Anne di Tommaso

|Aug 27, 2021
Critical role of IL-25-ILC2-IL-5 axis in the production of anti-Francisella LPS IgM by B1 B cells.

Carlos Henrique D Barbosa, Louis Lantier, Joseph Reynolds

|Jul 24, 2021
A Novel Calcium-Dependent Protein Kinase 1 Inhibitor Potently Prevents Toxoplasma gondii Transmission to Foetuses in Mouse.

Héloïse Débare, Nathalie Moiré, Firmin Baron

|Dec 01, 2020
Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer.

Louis Lantier, Agathe Poupée-Beaugé, Anne di Tommaso

Pageof 1

Frequent Collaborators

1 joint publications

Héloïse Débare

1 joint publications

Firmin Baron

1 joint publications

Françoise Debierre-Grockiego

1 joint publications

Carlos Henrique D Barbosa